TAN TRAN: Open Payments
NPI 1285621052 · WEST VALLEY CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,854 in 86 payments from 17 companies in 2025. Trend: 2023 $1,257 · 2024 $1,372 · 2025 $1,854
Food & beverage: $1,854
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $507 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $256 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $193 |
| AstraZeneca Pharmaceuticals LP | 5 | $184 |
| Kowa Pharmaceuticals America, Inc. | 5 | $171 |
| Indivior Inc. | 5 | $137 |
| GlaxoSmithKline, LLC. | 5 | $114 |
| Gilead Sciences, Inc. | 2 | $50 |
| Lilly USA, LLC | 3 | $45 |
| Novo Nordisk Inc | 2 | $33 |
Products named: Kerendia, VRAYLAR, JARDIANCE, ZORYVE, SUBLOCADE, BOTOX, LOKELMA, UBRELVY.
Industry payments across UT — which companies pay providers there.
